Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study
Author:
Bartoletti Michele1ORCID, Pascale Renato1, Cricca Monica2, Rinaldi Matteo1, Maccaro Angelo1, Bussini Linda1, Fornaro Giacomo1, Tonetti Tommaso3, Pizzilli Giacinto3, Francalanci Eugenia1, Giuntoli Lorenzo4, Rubin Arianna1, Moroni Alessandra2, Ambretti Simone2, Trapani Filippo1, Vatamanu Oana1, Ranieri Vito Marco3, Castelli Andrea5, Baiocchi Massimo5, Lewis Russell1, Giannella Maddalena1, Viale Pierluigi1, Raumer Luigi, Guerra Luca, Tumietto Fabio, Cascavilla Alessandra, Zamparini Eleonora, Verucchi Gabriella, Coladonato Simona, Ianniruberto Stefano, Attard Luciano, Volpato Marina Tadolini Francesca, Virgili Giulio, Rossi Nicolò, Del Turco Elena Rosselli, Guardigni Viola, Fasulo Giovanni, Dentale Nicola, Fulgaro Ciro, Legnani Giorgio, Campaci Emanuele, Basso Cristina, Zuppiroli Alberto, Passino Amalia Sanna, Tesini Giulia, Angelelli Lucia, Badeanu Adriana, Rossi Agostino, Santangelo Giulia, Dauti Flovia, Koprivika Vidak, Roncagli Nicholas, Tzimas Ioannis, Liuzzi Guido Maria, Baxhaku Irid, Pasinelli Letizia, Neri Mattia, Zanaboni Tommaso, Dell’Omo Francesco, Gori Alice, Zavatta Idina, Antonini Stefano, Pironi Chiara, Piccini Elena, Esposito Luca, Zuccotti Alessandro, Urbinati Giacomo, Pratelli Agnese, Sarti Alberto, Semprini Michela, Evangelisti Enrico, D’Onofrio Mara, Sasdelli Giuseppe,
Affiliation:
1. Infectious Diseases Unit, Department of Medical and Surgical Sciences, Policlinico Sant’Orsola, Bologna, Italy 2. Operative Unit of Microbiology, University of Bologna, Policlinico Sant’Orsola, Bologna, Italy 3. Intensive Care Unit, Department of Medical and Surgical Sciences, Policlinico Sant’Orsola, Bologna, Italy 4. Intensive Care Unit, Maggiore Hospital, Bologna, Italy 5. Cardio-Thoracic Anesthesiology Unit, S. Orsola Malpighi University Hospital, Bologna, Italy
Abstract
Abstract
Background
We evaluated the incidence of invasive pulmonary aspergillosis among intubated patients with critical COVID-19 and evaluated different case definitions of invasive aspergillosis.
Methods
Prospective, multicenter study in adult patients with microbiologically confirmed COVID-19 receiving mechanical ventilation. All included participants underwent a screening protocol for invasive pulmonary aspergillosis with bronchoalveolar lavage galactomannan and cultures performed on admission at 7 days and in case of clinical deterioration. Cases were classified as coronavirus-associated pulmonary aspergillosis (CAPA) according to previous consensus definitions. The new definition was compared with putative invasive pulmonary aspergillosis (PIPA).
Results
108 patients were enrolled. Probable CAPA was diagnosed in 30 (27.7%) patients after a median of 4 (2–8) days from intensive care unit (ICU) admission. Kaplan-Meier curves showed a significantly higher 30-day mortality rate from ICU admission among patients with either CAPA (44% vs 19%, P = .002) or PIPA (74% vs 26%, P < .001) when compared with patients not fulfilling criteria for aspergillosis. The association between CAPA (OR, 3.53; 95% CI, 1.29–9.67; P = .014) or PIPA (OR, 11.60; 95% CI, 3.24–41.29; P < .001) with 30-day mortality from ICU admission was confirmed, even after adjustment for confounders with a logistic regression model. Among patients with CAPA receiving voriconazole treatment (13 patients; 43%) a trend toward lower mortality (46% vs 59%; P = .30) and reduction in galactomannan index in consecutive samples were observed.
Conclusions
We found a high incidence of CAPA among critically ill COVID-19 patients and its occurrence seems to change the natural course of disease.
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Microbiology (medical)
Cited by
313 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|